The 2nd quarter financial results came out yesterday and, just as expected, OxySure Systems, Inc. (OXYS) crushed it nearly doubling all of 2012 revenues in Q2 alone. The report was the 2nd consecutive Q with 3X revenue growth rates all while the issued and outstanding shares of OXYS stock has barely increased since their 10K filing. How long money doesn’t begin to start flowing into the emergency oxygen providers and drive the PPS back to and over the 52 week high before the end of the year s beyond any kind of comprehension considering how small the float is.
Our Next Pick Is Coming Soon! Click HERE To Make Sure You Don’t Miss Any Of Our Breaking Alerts!
OXYS Stock Quote
Market Cap: 18.48M
Tuesday Close: 0.80
52Wk High: 2.75
52Wk Low: 0.35
10 Day Percent Change: +19.40%
10 Day Moving Average: 0.7583
10 Day Average Volume: 8,750
Issued and Outstanding: 24,027,346
Looking for Hot Penny Stocks?
Click here To Receive FREE Penny Stock Alerts
There is very little to speculate about which direction OxySure Systems is headed based on their Q2 results. Compared to the same period in 2012, Q2 revenues significantly increased (+657%), as did their gross profit (+758%), while G&A expenses (-18%), interest expense (-60%) and net loss (-11.8%) all improved to a point that should be recognized by even the dumbest of traders.
Year ended December 2012 revenues for OxySure were $269,697 whereas Q2 revenues just came in at $476,071. Add those numbers to Q1 and the $716,491 booked in the 1st half of 2013 has already beat all of 2012 revenues by 165%. At their current pace, they could easily book over $1.5 million in net sales which would be nearly 5X 2012 numbers.
OxySure’s CEO and Chairman, Julian T. Ross, commented on the Q2 results saying “Our growth in the second quarter represents another record as the benefits of prior and current research and development and marketing initiatives have begun to materialize. We are growing stronger, and we intend to continue to build on our positive momentum, while continuing to invest in branding, distribution, R&D and sales to drive our business plan forward.”
For those who understand what CEO comments mean for OTC stocks, the mere point that never did he feel the need to mention “increase shareholder value” or “maximize profits” is a clear sign that OXYS is the real deal and is going to be trading near r above its 5 week high within the next 6 months, a possible gain of 243% from its current level.
About OXYS Stock
OxySure Systems, Inc. is a medical technology company that focuses on the design, manufacture and distribution of specialty respiratory and emergency medical solutions.
Last 5 Trading Sessions:
If you can’t find a reason to see some significant upside on OXYS stock, perhaps you shouldn’t be trading penny stocks and should go after Facebook (FB) or Bank of America (BOA). It’s no oxymoron that OxySure’s OXYS is going to get some oxygen thrust into it and surge the share price over the course of the next 6 months making this, like we said before, a must own healthcare stock.
Here is your opportunity to subscribe to the Most Read Penny Stock Newsletter
If You Can’t Make Money With Us, You Shouldn’t Be Trading Penny Stocks
(We are 100% Anti-Spam and will never rent or sell your information)Share